TITLE

Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled Trial

AUTHOR(S)
Darenberg, Jessica; Ihendyane, Nahla; Sjölin, Jan; Aufwerber, Ewa; Haidl, Sven; Follin, Per; Andersson, Jan; Norrby-Teglund, Anna
PUB. DATE
August 2003
SOURCE
Clinical Infectious Diseases;8/1/2003, Vol. 37 Issue 3, p333
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Evaluates the efficacy and safety of high-dose intravenous polyspecific immunoglobulin G (IVIG) as adjunctive therapy in streptococcal toxic shock syndrome (STSS). Mortality rate; Decrease in the sepsis-related organ failure assessment score in the IVIG group; Increase in plasma neutralizing activity against superantigens expressed by autologous isolates.
ACCESSION #
10590144

 

Related Articles

  • Intravenous Immunoglobulin Therapy for Streptococcal Toxic Shock Syndrome--A Comparative Observational Study. Kaul, Rupert; McGeer, Allison; Norrby-Teglund, Anna; Kotb, Malak; Schwartz, Benjamin; O'Rourke, Keith; Talbot, James; Low, Donald E. // Clinical Infectious Diseases;4/1/1999, Vol. 28 Issue 4, p800 

    Presents the results of a comparative observational study which investigated the effect of an intravenous immunoglobulin therapy for streptococcal toxic shock syndrome. Methodology; Results; Discussion.

  • Reply to Arends and Harkisoen. Linnér, Anna; Sjölin, Jan; Darenberg, Jessica; Henriques-Normark, Birgitta; Norrby-Teglund, Anna // Clinical Infectious Diseases;Jan2015, Vol. 60 Issue 2, p324 

    A response from the authors of the article "Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study," published in a 2014 issue, is presented.

  • Dilemmas in the Treatment of Invasive Streptococcus pyogenes Infections. Stevens, Dennis L. // Clinical Infectious Diseases;8/1/2003, Vol. 37 Issue 3, p341 

    Introduces a study by J. Darenberg et al in the August 1, 2003 issue of the journal 'Clinical Infectious Diseases,' about the use of human polyspecific immunoglobulin G (IgG) as adjunctive therapy for streptococcal toxic shock syndrome (Strep TSS). Biological potency of the treatment;...

  • Assessing the Impact of Intravenous Immunoglobulin in the Management of Streptococcal Toxic Shock Syndrome: A Noble but Difficult Quest. Valiquette, Louis; Low, Donald E.; McGeer, Allison J. // Clinical Infectious Diseases;11/1/2009, Vol. 49 Issue 9, p1377 

    In this article the authors discuss the effectiveness of intravenous immunoglobulin (IVIG) for of streptococcal toxic shock syndrome (TSS). They cite the American Academy of Pediatrics Committee on Infectious Disease recommendations that IVIG should only be used when aggressive treatments to...

  • Dengue fever and Kawasaki disease: a clinical dilemma. Singh, Surjit; Jat, Kana; Suri, Deepti; Ratho, R. // Rheumatology International;Apr2009, Vol. 29 Issue 6, p717 

    There are several pediatric conditions which can present with fever and rash; however, it is uncommon to have two diseases occurring in a patient at the same time. We report a young child with fever and rash. He was initially diagnosed to have dengue fever based on clinical features and...

  • Anti-Aβ Oligomer IgG and Surface Sialic Acid in Intravenous Immunoglobulin: Measurement and Correlation with Clinical Outcomes in Alzheimer’s Disease Treatment. Kwon, Hyewon; Crisostomo, Amanda C.; Smalls, Hayley Marie; Finke, John M. // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    The fraction of IgG antibodies with anti-oligomeric Aβ affinity and surface sialic acid was compared between Octagam and Gammagard intravenous immunoglobulin (IVIG) using two complementary surface plasmon resonance methods. These comparisons were performed to identify if an elevated fraction...

  • Streptococcal Toxic Shock Syndrome: Two Case Reports. Cander, Başar; Çalık, Göknil; Gül, Mehmet; Ertekin, Birsen; Girişgin, Sadık // Journal of Academic Emergency Medicine / Akademik Acil Tip Olgu ;2013, Vol. 12 Issue 1, p49 

    Streptococcal toxic shock syndrome (STSS), the most common complication of skin infection is caused by a streptoccus. This syndrome is characterized by fever, hypotension and multiple organ failure. A 64 year old male patient with sudden onset of facial swelling and redness in the eye was...

  • Prominent Plasmacytosis Following Intravenous Immunoglobulin Correlates with Clinical Improvement in Guillain-Barré Syndrome. Mori, Izumi; Parizot, Christophe; Dorgham, Karim; Demeret, Sophie; Amoura, Zahir; Francis Bolgert; Gorochov, Guy // PLoS ONE;2008, Vol. 3 Issue 5, p1 

    Background: High doses of pooled polyclonal IgG are commonly used to treat numerous autoimmune diseases. Their mode of action nevertheless remains only partially explained. At the same time, until now, no early biological marker has been able to predict their efficacy. Methodology/Principal...

  • Role of intravenous immune globulin in streptococcal toxic shock syndrome and Clostridium difficile infection. SHAH, PUNIT J.; VAKIL, NIYATI; KABAKOV, ANNA // American Journal of Health-System Pharmacy;p1013 

    Purpose. The use of intravenous immune globulin (IVIG) in the management of streptococcal toxic shock syndrome (STSS) and Clostridium difficile infection (CDI) is reviewed. Summary. IVIG has a wide range of uses in clinical practice, including STSS and CDI. It is an attractive option for these...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics